October 20, 2017 12:33 PM ET


Company Overview of Xigen SA

Company Overview

Xigen SA, a biopharmaceutical company, researches and develops therapeutic peptides for the treatment of inflammatory diseases. The company’s technology enables the design and synthesis of cell-penetrating peptides, using proprietary carrier motifs to deliver them to intracellular targets in disease relevant cell types. It develops Brimapitide (XG-102) with programs in ocular inflammation, urology, nephrology, and Alzheimer’s disease. The company was founded in 2002 and is based in Epalinges, Switzerland.

Route de la corniche 4

Epalinges,  1066


Founded in 2002


41 21 321 10 80


41 21 321 10 81

Key Executives for Xigen SA

Legal, Administrative, and Financial Director
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
4bases S.A. Europe
AB2 Bio Ltd. Europe
ADC Products Switzerland SARL Europe
ADC Therapeutics SA Europe
AlloCyte Pharmaceuticals AG Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
Bertelsmann AG Europe

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Xigen SA, please visit www.xigenpharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.